Jiangyan Zhou

No ORCID on file · 7 papers in corpus · active 2011-2022

Study types

  • article 7

Condition tags

  • endometriosis 5
  • adenomyosis 2
  • dysmenorrhea 1
article 2022
Whole-exome sequencing and functional validation reveal a rare missense variant in MMP7 that confers ovarian endometriosis risk
Human molecular genetics ·doi:10.1093/hmg/ddac062

Prior studies have shown that genetic factors play important roles in ovarian endometriosis. Herein, we first analyzed the whole-exome sequencing data from 158 patients with ovarian endometriosis and 385 local control women without endometr…

article 2021
Endometrial stromal cell proteomic analysis reveals LIM and SH3 protein 1 (LASP1) plays important roles in the progression of adenomyosis
Molecular human reproduction ·doi:10.1093/molehr/gaab008

Adenomyosis is one of the most common gynecological disorders that the molecular events underlying its pathogenesis remain not fully understood. Prior studies have shown that endometrial stromal cells (ESCs) played crucial roles in the path…

article 2021
Frequent DYSF rare variants/mutations in 152 Han Chinese samples with ovarian endometriosis
Archives of gynecology and obstetrics ·doi:10.1007/s00404-021-06094-8
article 2018
Analysis of CARD10 and CARD11 somatic mutations in patients with ovarian endometriosis
Oncology letters ·doi:10.3892/ol.2018.8659

Endometriosis is a complex and heterogeneous pre-malignant inflammatory disease harboring multiple gene mutations. Previous studies have suggested that caspase recruitment domain family member (CARD)10 and CARD11 mutations may exist in endo…

article 2018
Mutation analysis of ZP1, ZP2, ZP3 and ZP4 genes in 152 Han Chinese samples with ovarian endometriosis
Mutation research ·doi:10.1016/j.mrfmmm.2018.12.003
article 2018
The presence of KRAS, PPP2R1A and ARID1A mutations in 101 Chinese samples with ovarian endometriosis
Mutation research ·doi:10.1016/j.mrfmmm.2018.03.001
article 2011
The Analysis of LNG-IUS in the Treatment of 98 Adenomyosis

Objective To investigate the clinical efficacy of levonorgestrel-releasing intrauterine system(LNG-IUS)in treating adenomyosis.Methods Ninty-eight patients with adenomysois were followed up in 1,3,6,9 months after placing LNG-IUS dysmenorrh…